First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer. (Q40041145)
Jump to navigation
Jump to search
scientific article published on December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer. |
scientific article published on December 2007 |
Statements
First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer (English)
Arkadiusz Z Dudek
Carla Yunis
Lester I Harrison
Sandeep Kumar
Ronald Hawkinson
John P Vasilakos
Kevin S Gorski
1 December 2007